Data as of Q4 2025 (Dec 31, 2025)
MIST

MILESTONE PHARMACEUTICALS IN

Institutional Ownership ยท Q4 2025

Filing: Q4 2025

MILESTONE PHARMACEUTICALS IN (MIST) is held by 72 institutional investors with combined holdings of $1.4B. Major holders include Stonepine Capital Managem, Propel Bio Management, LL, ADAGE CAPITAL PARTNERS GP.

Institutional Holders
72
Total Value
$1.4B
Ownership %
20.2%